Relationship Between STOP BANG Score and Airway Management
NCT ID: NCT05640856
Last Updated: 2022-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1 participants
OBSERVATIONAL
2021-01-01
2022-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
STOP-Bang Questionnaire: A Predictor of Obstructive Sleep Apnea and Difficult Mask/Intubation?
NCT06247631
Examining the Effects of Anthropometric Measurements on Difficult Airway Prediction
NCT07077317
OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia
NCT06430957
Postoperative SpO₂/FiO₂ in Obese and Non-Obese Patients: Role of STOP-BANG
NCT07188649
Airway Ultrasound vs Clinical Predictors for Difficult Airway
NCT07243106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group D
STOP BANG Score \<3
intubation
Endotracheal tube placement
Group Y
STOP BANG Score ≥ 3
intubation
Endotracheal tube placement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intubation
Endotracheal tube placement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between 18-65 years old
* Volunteered to participate in the study
Exclusion Criteria
* morbidly obese (BMI\>45 kg/m2),
* patients with a history of alcohol or drug addiction
* women in pregnancy or lactation
* allergic to the drugs used in the study
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zonguldak Bulent Ecevit University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bengü Gülhan Köksal
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zonguldak Bülent Ecevit University Medicine Faculty
Zonguldak, Kozlu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-22/16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.